NCT01695187View on ClinicalTrials.gov

NB-001 Treatment of Recurrent Herpes Labialis

PHASE3UnknownINTERVENTIONAL
Enrollment

362

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

July 31, 2013

Conditions
Herpes Labialis
Interventions
DRUG

NB-001 (0.3%)

Topical administration at least five times throughout the day

DRUG

Placebo

Trial Locations (12)

24073

New River Valley Research Institute, Christiansburg

29464

Coastal Carolina Research Center, Mt. Pleasant

29621

Radiant Research, Inc., Anderson

40509

Central Kentucky Research Associates, Inc., Lexington

55435

Radiant Research, Inc., Edina

60654

Radiant Research, Inc. Chicago, Chicago

63141

Radiant Research, Inc., St Louis

64114

The Center for Pharmaceutical Research, P.C., Kansas City

75234

Research Across America, Dallas

78229

Radiant Research, Inc., San Antonio

85224

Radiant Research, Inc, Chandler

85710

Radiant Research, Inc, Tucson

Sponsors
All Listed Sponsors
lead

NanoBio Corporation

INDUSTRY

NCT01695187 - NB-001 Treatment of Recurrent Herpes Labialis | Biotech Hunter | Biotech Hunter